AMF Medical and Sensars receive FDA Breakthrough Device Designation
December 3, 2021
Two Swiss start-ups have been granted FDA Breakthrough Device Designation recently: AMF for its Sigi Insulin Management system and Sensars for its system providing sensory feedback for those with limb loss to improve prosthesis function.
Read more here.
Sensars gets funding of €1.1M to advance its SENSY product.
May, 2024
Sensars has received a pre-seed investment from HTH, a prominent VC investor dedicated to improving human health. This funding injection will support Sensars’ ongoing activities to develop groundbreaking solutions for chronic pain sufferers.
Read more here.
SensArs Neuroprosthetics Wins €3 Million European Funding to Refine its Sensation-Giving Leg Prosthesis
October 8, 2019
SensArs will lead the GoSafe project group that includes Ossur, the world’s second-largest prosthesis manufacturer, and clinical centers in Italy and Germany. Co-founder and CEO, Francesco Petrini, recalls his early kicks with Venture Kick.
Read more here.
SensArs coordinates a €3 million grant to test its bionic prosthetics
October 7, 2019
SensArs Neuroprosthetics has received a 3 million EUR grant as part of the European Union’s Horizon Research and Innovation program. The startup will coordinate and use the funds to further develop and test its product – the neuroprosthetic system.
Read more on here.
